Skip to main content

Advertisement

Table 1 Patient characteristics (FIGO stage, grading) and type of hypoglycemic drug

From: Does Metformin affect ER, PR, IGF-1R, β-catenin and PAX-2 expression in women with diabetes mellitus and endometrial cancer?

Endometrial cancer (n = 86)
  Metformin in monotherapy Metformin + other drugs Insulin in monotherapy Sulfonylurea derivatives Non- diabetics (control)
  (n = 22) (n = 10) (n = 10) (n = 6) (n = 38)
FIGO I 19 9 8 6 32
FIGO II-IV 3 1 2 0 6
G1 8 6 6 3 23
G2 13 3 3 3 11
G3 1 1 1 0 4